Intech Biopharm

益得生物科技股份有限公司 · 6461

What it does

Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.

Intech Biopharm researches, develops, manufactures, and sells pharmaceuticals, specializing in generic and new drugs for respiratory diseases such as asthma, as well as new drug development in fields such as anti-cancer.^[1]

The company specializes in metered-dose inhaler (MDI) research and development, inspection and analysis, and production, and maintains a technology platform for HFA MDI.^[2]

It develops new compound drugs, new dosage form drugs, and high-barrier generic drugs for respiratory-related treatments.^[3]

The company provides prescription development and manufacturing services to customers through CDMO cooperation.^[2]

Monthly revenue

Latest month	Revenue	Year on year	Month on month
2026-10	NT$0m	-99.7%	-99.9%

2024-11 to 2026-10, monthly revenue.

Foreign investors

Last 20 trading days	Net
2026-10-12 to 2026-11-10	+NT$1m

Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.

Facts

Full English name	Intech Biopharm Ltd.
Chinese name	益得生物科技股份有限公司
Stock code	6461 (TPEx)
Industry	Biotech & medical
Founded	28 Oct 2010
Listed	28 Mar 2018
Paid-in capital	NT$1.1bn
Chairman	林智暉
President	Manish Chawla
Headquarters	No. 20, Guangfu Rd., Hukou Township, Hsinchu County 303036, T
Website	http://www.intechbiopharm.com
Official business description	藥品研發、製造及銷售

Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.

Sources

MOPS 公司基本資料益得生物科技股份有限公司 · mops · retrieved 04 Nov 2026
Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
益得生物科技股份有限公司 · website · retrieved 04 Nov 2026

The Week in Taiwan Companies · free, every Friday
Using it at work? Join the team-plan waiting list